Page last updated: 2024-10-15

dinitrochlorobenzene and Acute Myelogenous Leukemia

dinitrochlorobenzene has been researched along with Acute Myelogenous Leukemia in 1 studies

Dinitrochlorobenzene: A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds.
1-chloro-2,4-dinitrobenzene : A C-nitro compound that is chlorobenzene carrying a nitro substituent at each of the 2- and 4-positions.

Research Excerpts

ExcerptRelevanceReference
"In acute non-lymphocytic leukemia (ANLL) patients, the 50% survival durations were 11 months in the PPD positive group and 6 months in the PPD negative group."1.26The relationship of cellular immunity to prognosis in acute leukemia. ( Chen, P; Kitajima, K; Naito, T; Nakanishi, N; Takahashi, I; Takahashi, Y; Toki, H, 1977)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Toki, H1
Takahashi, Y1
Nakanishi, N1
Naito, T1
Chen, P1
Takahashi, I1
Kitajima, K1

Other Studies

1 other study available for dinitrochlorobenzene and Acute Myelogenous Leukemia

ArticleYear
The relationship of cellular immunity to prognosis in acute leukemia.
    Acta medica Okayama, 1977, Volume: 31, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Aged; Dinitrochlorobenzene; Female; Humans; Immunity, Cellular; Le

1977